Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Safety
  4. Fast Track Articles
  5. Fast Track Article
image of Advancements in Colon Cancer Therapy: A Review on Docetaxel and the Role of Nanotechnology in Enhancing Efficacy

Abstract

Docetaxel exhibits high protein binding and P450-mediated metabolism, which influences its pharmacokinetics. As a taxane-family chemotherapeutic agent, it stabilizes microtubules and disrupts cell division. Combining docetaxel with agents like 5-fluorouracil and oxaliplatin enhances treatment outcomes for colon cancer. Emerging drug delivery systems, including nanoparticles and micelles, aim to improve efficacy while reducing toxicity. However, its safety during pregnancy remains uncertain, and ongoing clinical trials continue to evaluate its therapeutic potential.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863353992250207115526
2025-01-14
2025-06-23

  • From This Site

    /content/journals/cds/10.2174/0115748863353992250207115526
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Grigorean V.T. Erchid A. Coman I.S. Liţescu M. Colorectal cancer—the “parent” of low bowel obstruction. Medicina 2023 59 5 875 10.3390/medicina59050875 37241107
    [Google Scholar]
  2. Bortz J.H. Polyps: Types and sizes. CT Colonography for Radiographers: A Guide to Performance and Image Interpretation. Springer 2023 181 207 10.1007/978‑3‑031‑30866‑6_14
    [Google Scholar]
  3. Kumar S. Diseases of Digestive System. Diamond Pocket Books (P) Ltd 2024 10.1079/9781800624788.0008
    [Google Scholar]
  4. Hamilton W. Bailey S.E.R. Colorectal cancer in symptomatic patients: How to improve the diagnostic pathway. Best Pract. Res. Clin. Gastroenterol. 2023 66 101842 10.1016/j.bpg.2023.101842 37852715
    [Google Scholar]
  5. Dey A. Mitra A. Pathak S. Prasad S. Zhang A.S. Zhang H. Sun X.F. Banerjee A. Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer. Technol. Cancer Res. Treat. 2023 22 15330338231178403 10.1177/15330338231178403 37248615
    [Google Scholar]
  6. Stjärngrim J. Colorectal cancer in inflammatory bowel disease: Aspects on post-colonoscopy colorectal cancer. Solna Karolinska Institute, Stockholm. Sweden 2023
    [Google Scholar]
  7. Beheshtizadeh N. Amiri Z. Tabatabaei S.Z. Seraji A.A. Gharibshahian M. Nadi A. Saeinasab M. Sefat F. Kolahi Azar H. Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: From cancer therapy to regenerative medicine approaches. J. Transl. Med. 2024 22 1 520 10.1186/s12967‑024‑05347‑9 38816723
    [Google Scholar]
  8. Kietzmann D. Emergencies and critical incidents. Anaesthesia in Remote Hospitals: A Guide for Anaesthesia Providers Springer 2024 191 208
    [Google Scholar]
  9. Virendra S.A. Chawla P.A. Singh S. Exploring the role of ADME for anticancer prodrugs. Handbook of Oncobiology: From Basic to Clinical Sciences Springer 2023 1 16 10.1007/978‑981‑99‑2196‑6_56‑1
    [Google Scholar]
  10. Jiang X. Qu A. Xu X. Kuang H. Liu L. Xu C. A gold-based multiplex immunochromatographic sensor for detecting paclitaxel, methotrexate, and 5-fluorouracil in clinical samples. Nano Res. 2024 17 7 6420 6429 10.1007/s12274‑024‑6649‑7
    [Google Scholar]
  11. Yamashita K. Hosoda K. Niihara M. Hiki N. History and emerging trends in chemotherapy for gastric cancer. Ann. Gastroenterol. Surg. 2021 5 4 446 456 10.1002/ags3.12439 34337293
    [Google Scholar]
  12. Yu Z. Li X. Duan J. Yang X.D. Targeted treatment of colon cancer with aptamer-guided albumin nanoparticles loaded with docetaxel. Int. J. Nanomedicine 2020 15 6737 6748 10.2147/IJN.S267177 32982230
    [Google Scholar]
  13. Wang Y. Zhu Y. Clinical effectiveness and safety of gemcitabine plus capecitabine in the treatment of advanced triple-negative breast cancer. Am. J. Transl. Res. 2024 16 5 1945 1952 10.62347/QOWN3646 38883354
    [Google Scholar]
  14. Di Filippo L.D. Lobato Duarte J. Hofstätter Azambuja J. Isler Mancuso R. Tavares Luiz M. Hugo Sousa Araújo V. Delbone Figueiredo I. Barretto-de-Souza L. Miguel Sábio R. Sasso-Cerri E. Martins Baviera A. Crestani C.C. Teresinha Ollala Saad S. Chorilli M. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression. Int. J. Pharm. 2022 618 121682 10.1016/j.ijpharm.2022.121682 35307470
    [Google Scholar]
  15. Jiang C. Zhou Q. Yi K. Yuan Y. Xie X. Colorectal cancer initiation: Understanding early-stage disease for intervention. Cancer Lett. 2024 589 216831 10.1016/j.canlet.2024.216831 38574882
    [Google Scholar]
  16. Weledji E. The etiology and pathogenesis of colorectal cancer. Clin. Oncol. 2024 9 2046
    [Google Scholar]
  17. Rajput S. Kumar Sharma P. Malviya R. Fluid mechanics in circulating tumour cells: Role in metastasis and treatment strategies. Med. Drug Discov. 2023 18 100158 10.1016/j.medidd.2023.100158
    [Google Scholar]
  18. Bou Antoun N. Chioni A.M. Dysregulated signalling pathways driving anticancer drug resistance. Int. J. Mol. Sci. 2023 24 15 12222 10.3390/ijms241512222 37569598
    [Google Scholar]
  19. Xu A.P. Xu L.B. Smith E.R. Fleishman J.S. Chen Z.S. Xu X.X. Cell death in cancer chemotherapy using taxanes. Front. Pharmacol. 2024 14 1338633 10.3389/fphar.2023.1338633 38249350
    [Google Scholar]
  20. Komal Nanda B.P. Singh L. Bhatia R. Singh A. Paclitaxel in colon cancer management: From conventional chemotherapy to advanced nanocarrier delivery systems. Naunyn Schmiedebergs Arch. Pharmacol. 2024 397 12 9449 9474 10.1007/s00210‑024‑03256‑8 38990305
    [Google Scholar]
  21. Sati P. Sharma E. Dhyani P. Attri D.C. Rana R. Kiyekbayeva L. Büsselberg D. Samuel S.M. Sharifi-Rad J. Paclitaxel and its semi-synthetic derivatives: Comprehensive insights into chemical structure, mechanisms of action, and anticancer properties. Eur. J. Med. Res. 2024 29 1 90 10.1186/s40001‑024‑01657‑2 38291541
    [Google Scholar]
  22. Alemdar A. Duman M.G. Sengiz Erhan S. Sasako M. Histopathologic response in patients with curative resection with D2 dissection following neoadjuvant treatment for locally advanced gastric and esophagogastric junction adenocarcinoma. Eur. J. Surg. Oncol. 2024 50 7 108428 10.1016/j.ejso.2024.108428 38795679
    [Google Scholar]
  23. Le D.T. Bui L.T. Nguyen C.V. Do K.H. Tran G.L. Do T.A. Neoadjuvant doxorubicin-paclitaxel combined chemotherapy in patients with inoperable stage III breast cancer: A retrospective cohort study with 10 years of follow-up in Vietnam. Oncol. Ther. 2023 11 3 327 341 10.1007/s40487‑023‑00233‑8 37289321
    [Google Scholar]
  24. Thiruchenthooran V. Sánchez-López E. Gliszczyńska A. Perspectives of the application of non-steroidal anti-inflammatory drugs in cancer therapy: Attempts to overcome their unfavorable side effects. Cancers 2023 15 2 475 10.3390/cancers15020475 36672424
    [Google Scholar]
  25. Miyake T. Mochizuki T. Nakagawa T. Nakamura M. Emoto C. Komiyama N. Hirabayashi M. Tsuruta S. Shimojo T. Terao K. Tachibana T. Quantitative prediction of CYP3A‐mediated drug–drug interactions by correctly estimating fraction metabolized using human liver chimeric mice. Br. J. Pharmacol. 2024 181 7 1091 1106 10.1111/bph.16270 37872109
    [Google Scholar]
  26. Yukuyama M.N. de Souza A. Henostroza M.A.B. de Araujo G.L.B. Löbenberg R. Faria R.O. de Souza G.B. Guimaraes L.M.F. Lameu C. Folchini B.R. Peroni C.M. Oliveira I.F. Miyagi M.Y.S. Bou-Chacra N.A. Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment. J. Drug Deliv. Sci. Technol. 2023 89 105017 10.1016/j.jddst.2023.105017
    [Google Scholar]
  27. Kar A. Agarwal S. Singh A. Bajaj A. Dasgupta U. Insights into molecular mechanisms of chemotherapy resistance in cancer. Transl. Oncol. 2024 42 101901 10.1016/j.tranon.2024.101901 38341963
    [Google Scholar]
  28. Liang S. Xiao L. Chen T. Roa P. Cocco E. Peng Z. Yu L. Wu M. Liu J. Zhao X. Deng W. Wang X. Zhao C. Deng Y. Mai Y. Injectable nanocomposite hydrogels improve intraperitoneal co-delivery of chemotherapeutics and immune checkpoint inhibitors for enhanced peritoneal metastasis therapy. ACS Nano 2024 18 29 18963 18979 10.1021/acsnano.4c02312 39004822
    [Google Scholar]
  29. Rodrigues Arruda B. Mendes M.G.A. Freitas P.G.C. Reis A.V.F. Soares Lima T. Crisóstomo L.C.C.F. Nogueira K.A.B. Pessoa C. Petrilli R. Eloy J.O. Nanocarriers for delivery of taxanes: A review on physicochemical and biological aspects. J. Drug Deliv. Sci. Technol. 2023 80 104070 10.1016/j.jddst.2022.104070
    [Google Scholar]
  30. Agnihotri V. Taxus baccata subsp. wallichiana (Zucc.) Pilg. Himalayan Fruits and Berries Elsevier 2023
    [Google Scholar]
  31. Zhang S. Ye T. Liu Y. Hou G. Wang Q. Zhao F. Li F. Meng Q. Research advances in clinical applications, anticancer mechanism, total chemical synthesis, semi-synthesis and biosynthesis of paclitaxel. Molecules 2023 28 22 7517 10.3390/molecules28227517 38005238
    [Google Scholar]
  32. Yang C. Wang Y. Su Z. Xiong L. Wang P. Lei W. Yan X. Ma D. Zhao G. Zhou Z. Biosynthesis of the highly oxygenated tetracyclic core skeleton of Taxol. Nat. Commun. 2024 15 1 2339 10.1038/s41467‑024‑46583‑3 38490987
    [Google Scholar]
  33. Li F. Lin H. Feng S. Cai L. Zhang L. Feng S. Liu X. Chen Z. Zou Q. Wu Y. Su X. Shen K. Yu Q. A phase I, single‐sequence, open‐label study to evaluate the drug–drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects. Br. J. Clin. Pharmacol. 2023 89 7 2160 2167 10.1111/bcp.15664 36654488
    [Google Scholar]
  34. Wang D. Hung N. Hung T. Eden K. Chan W-K. Kwan R. Qin A. Chang C. Duffull S. Glue P. Jackson C. Oral docetaxel plus encequidar – A phase 1 clinical trial. Cancer Chemother. Pharmacol. 2024 94 3 475 481 10.1007/s00280‑024‑04674‑4
    [Google Scholar]
  35. Panthi V.K. Bashyal S. Paudel K.R. Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives. J. Drug Deliv. Sci. Technol. 2023 ••• 105314
    [Google Scholar]
  36. Machado T. Nanoparticle Clearance: A Regulatory Summary Recommending Strengthening of the Current FDA Guidance in Assuring Long Term Safety of Nanoparticle Therapies in Cancer Patients. Harvard University 2023
    [Google Scholar]
  37. Boddu P.C. Senapati J. Ravandi-Kashani F. Jabbour E.J. Jain N. Ayres M. Chen Y. Keating M.J. Kantarjian H.M. Gandhi V. Kadia T.M. A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies. Cancer 2023 129 4 580 589 10.1002/cncr.34570 36448227
    [Google Scholar]
  38. Zheng Q. He S. Xu S.L. Ma M.D. Fan M. Ge J.F. Pharmacokinetics and tissue distribution of vigabatrin enantiomers in rats. Saudi Pharm. J. 2024 32 2 101934 10.1016/j.jsps.2023.101934 38223203
    [Google Scholar]
  39. Kuhn A.J. A multi-compartment pharmacokinetic model of docetaxel. Lethbridge, Alta. University of Lethbridge, Dept. of Physics and Astronomy 2023
    [Google Scholar]
  40. Narasinghe S. Depletion of ABCC10 in human colorectal Caco-2 cancer cells using the CRISPR-Cas9 system. Auckland University of Technology 2024
    [Google Scholar]
  41. Mule S. Pawar V. Tekade M. Vasdev N. Gupta T. Singh A. Sarker S.D. Tekade R.K. Psychopharmacology in late life: Key challenges and opportunities. Public Health Toxicol Issues Drug Res. 2024 2 755 785 10.1016/B978‑0‑443‑15842‑1.00026‑0
    [Google Scholar]
  42. Fujita K. Matsumoto N. Ishida H. Kubota Y. Iwai S. Shibanuma M. Kato Y. Decreased disposition of anticancer drugs predominantly eliminated via the liver in patients with renal failure. Curr. Drug Metab. 2019 20 5 361 376 10.2174/1389200220666190402143125 30947665
    [Google Scholar]
  43. Rosser S.P.A. Exploring pharmacological variability of myeloablative conditioning agents in children receiving haematopoietic stem cell transplantation. Thesis, Doctor of Philosophy 2024
    [Google Scholar]
  44. Çetin O. Güngör B. İçhedef Ç. Parlak Y. Bilgin E.S. Üstün F. Durmuş Altun G. Başpınar Y. Teksöz S. Development of a radiolabeled folate-mediated drug delivery system for effective delivery of docetaxel. ACS Omega 2023 8 28 25316 25325 10.1021/acsomega.3c02656 37483227
    [Google Scholar]
  45. Parida L. Patel T.N. Systemic impact of heavy metals and their role in cancer development: A review. Environ. Monit. Assess. 2023 195 6 766 10.1007/s10661‑023‑11399‑z 37249740
    [Google Scholar]
  46. Salem S.S. A comprehensive review of nanomaterials: Types, synthesis, characterization, and applications. Biointerface Res. Appl. Chem. 2022 13 1 41 10.33263/BRIAC131.041
    [Google Scholar]
  47. Khan I. Saeed K. Khan I. Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. 2019 12 7 908 931 10.1016/j.arabjc.2017.05.011
    [Google Scholar]
  48. Sohni S. Nanotechnology for Safe and Sustainable Environment: Realm of Wonders. Bentham Science 2018 37 117 10.2174/9781681086453118020004
    [Google Scholar]
  49. Ghosh S. Ray A. Pramanik N. Self-assembly of surfactants: An overview on general aspects of amphiphiles. Biophys. Chem. 2020 265 106429 10.1016/j.bpc.2020.106429 32693319
    [Google Scholar]
  50. Hanafy N. El-Kemary M. Leporatti S. Micelles structure development as a strategy to improve smart cancer therapy. Cancers 2018 10 7 238 10.3390/cancers10070238 30037052
    [Google Scholar]
  51. Gahrooee T.R. Abbasi Moud A. Danesh M. Hatzikiriakos S.G. Rheological characterization of CNC-CTAB network below and above critical micelle concentration (CMC). Carbohydr. Polym. 2021 257 117552 10.1016/j.carbpol.2020.117552 33541625
    [Google Scholar]
  52. Chiu H.I. Lim V. Wheat germ agglutinin-conjugated disulfide cross-linked alginate nanoparticles as a docetaxel carrier for colon cancer therapy. Int. J. Nanomedicine 2021 16 2995 3020 10.2147/IJN.S302238 33911862
    [Google Scholar]
  53. Cassano R. Trombino S. Curcio F. Sole R. Calviello G. Serini S. ROS-responsive PLGA-NPs for co-delivery of DTX and DHA for colon cancer treatment. Int J Transl Med. 2024 4 2 262 277 10.3390/ijtm4020016
    [Google Scholar]
  54. Kazemi M. Emami J. Hasanzadeh F. Minaiyan M. Mirian M. Lavasanifar A. Mokhtari M. In vitro and in vivo evaluation of novel DTX-loaded multifunctional heparin-based polymeric micelles targeting folate receptors and endosomes. Recent Patents Anticancer Drug Discov. 2020 15 4 341 359 10.2174/1574892815666201006124604 33023456
    [Google Scholar]
  55. Ghamkhari A. Pouyafar A. Salehi R. Rahbarghazi R. Chrysin and docetaxel loaded biodegradable micelle for combination chemotherapy of cancer stem cell. Pharm. Res. 2019 36 12 165 10.1007/s11095‑019‑2694‑4 31646391
    [Google Scholar]
  56. Bhardwaj J.K. Bikal P. Sachdeva S.N. Chemotherapeutic drugs induced female reproductive toxicity and treatment strategies. J. Biochem. Mol. Toxicol. 2023 37 7 e23371 10.1002/jbt.23371 37098697
    [Google Scholar]
  57. Grimes H. Ansari M. Ashraf T. Cueto-González A.M. Calder A. Day M. Fernandez Alvarez P. Foster A. Lahiri N. Repetto G.M. Scurr I. Varghese V. Low K.J. PUF60 ‐related developmental disorder: A case series and phenotypic analysis of 10 additional patients with monoallelic PUF60 variants. Am. J. Med. Genet. A. 2023 191 10 2610 2622 10.1002/ajmg.a.63313 37303278
    [Google Scholar]
  58. Lu Z. Guo Y. Xu D. Xiao H. Dai Y. Liu K. Chen L. Wang H. Developmental toxicity and programming alterations of multiple organs in offspring induced by medication during pregnancy. Acta Pharm. Sin. B 2023 13 2 460 477 10.1016/j.apsb.2022.05.029 36873163
    [Google Scholar]
  59. Piantadosi S. Clinical trials: A methodologic perspective. John Wiley & Sons 2024
    [Google Scholar]
  60. Tharmaraj P. Shakina J. Principles Of IPR. AG PUBLISHING HOUSE 2023
    [Google Scholar]
  61. Avaialable from: https://clinicaltrials.gov/search?cond=colon%20cancer&intr=Docetaxel&page=2
  62. Docetaxel and human serum albumin complexes. U.S. Patent 10780172B2 2016
  63. Avaialable from: https://patents.google.com/?q=(DOCETAXEL)&oq=DOCETAXEL
/content/journals/cds/10.2174/0115748863353992250207115526
Loading
Advancements in Colon Cancer Therapy: A Review on Docetaxel and the Role of Nanotechnology in Enhancing Efficacy
Bentham Science Publishers ; https://doi.org/10.2174/0115748863353992250207115526
/content/journals/cds/10.2174/0115748863353992250207115526
/content/journals/cds/10.2174/0115748863353992250207115526
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: chemotherapy ; microtubule stabilization ; Colon cancer ; drug delivery systems ; pharmacokinetics ; clinical trials ; docetaxel ; nanoparticles ; micelles

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test